Mobile
Drug Class Comparison Charts

Articles
[2] how to manage hypokalemia in patients on diuretics (hydrochlorothiazide, furosemide, etc) (9/14)
[3] Tanzeum (TAN-zee-um, albiglutide) will be another GLP-1 agonist for diabetes (8/14)
[4] three new antiepileptic drugs called Qudexy XR (cue-DEKS-ee), Fycompa (fi-COM-puh), and Aptiom (AP-tee-om) (8/14)
[5] how to use the new cholesterol guidelines in "real world" patients (7/14)
[6] more emphasis on improving colon cancer screening (3/14)
[7] skyrocketing costs of GENERIC drugs (3/14)
[8] more lipid drugs get indications based on HARD clinical outcomes (12/13)
[9] two new antidepressants, Brintellix (brin-TEL-ix, vortioxetine) and Fetzima (fet-ZEE-muh, levomilnacipran) (12/13)
[0] More patients who are allergic to penicillin will get a cephalosporin for common respiratory tract infections (10/13)
[-] new FOUR-phase extended-cycle oral contraceptive, Quartette (kwor-TET, levonorgestrel/ethinyl estradiol) (9/13)
[-] new warnings about olmesartan (Benicar, etc) and serious GI problems (9/13)
[-] more debate about using antithrombotics to prevent strokes in elderly patients with atrial fibrillation (8/13)
[-] new ezetimibe and statin combo for dyslipidemia called Liptruzet (LIP-true-zet) (7/13)
[-] how to manage stimulant side effects in kids and teens with ADHD (3/13)
[-] approval of Eliquis (ELL-eh-kwiss, apixaban) will intensify the marketing war among the NEW oral anticoagulants (2/13)
[-] Niacin will continue to fall out of favor for dyslipidemia (2/13)
[-] three more pancrelipase products, Ultresa (ul-TRES-a), Viokace (VYE-oh-kase), and Pertzye (PERT-zye) (1/13)
[-] Beta-blockers will continue to fall out of favor for hypertension (1/13)
[-] Xarelto (rivaroxaban) will be used to TREAT venous thromboembolism (12/12)
[-] bigger push to limit NSAIDs in heart attack patients INDEFINITELY (11/12)
[-] About 25% of your patients over age 65 have type 2 diabetes (11/12)
[-] whether it makes sense to use more than one antipsychotic for schizophrenia (10/12)
[-] supplies of the direct thrombin inhibitor lepirudin (Refludan) dwindle over the next few months (8/12)
-- Comparison of Injectable Anticoagulants
-- CHART
[-] take both a GLP-1 agonist (Byetta, etc) and DPP-4 inhibitor (Januvia, etc) for type 2 diabetes (8/12)
-- Combining a GLP-1 Agonist and a DPP-4 Inhibitor for Type 2 Diabetes
-- CHART
[-] Keeping track of the different spectrums of the IV and oral cephalosporins can be a real challenge (7/12)
-- Comparison of Cephalosporins
-- CHART
[-] When to use an ORAL cephalosporin and which one (7/12)
-- Comparison of Cephalosporins
-- CHART
[-] more guidance on what to use to prevent migraine (7/12)
-- Strategies for Preventing Migraine Headaches
-- CHART
[-] a more "patient-centered" approach for choosing meds to add to metformin for type 2 diabetes (6/12)
-- Choosing Diabetes Meds to Add to Metformin
-- CHART
[-] Gelnique 3% for overactive bladder (5/12)
[-] Statin patients will get fewer liver function tests (5/12)
-- When to Monitor Liver Enzymes for Patients Taking Statins
-- CHART
[-] Brilinta (ticagrelor) for acute coronary syndrome (5/12)
-- Which Antiplatelet Drug to Add to Aspirin for Acute Coronary Syndrome
-- CHART
[-] more generic ARBs in 2012 (3/12)
-- New Generic ARBs
-- CHART
[-] Bydureon (by-DUR-ee-on), a new long-acting form of Byetta (exenatide) for type 2 diabetes (3/12)
-- New Once WEEKLY Exenatide (Bydureon)
-- CHART
[-] whether ADHD stimulants increase cardiovascular risk or substance abuse in ADULTS (2/12)
-- Adults with ADHD: Cardiovascular Risk and Substance Abuse Considerations
-- CHART
[-] Carisoprodol (Soma, etc) will finally be a Schedule IV controlled substance in ALL states (1/12)
-- Carisoprodol: Schedule IV Controlled Substance Nationwide
-- CHART
[-] comparisons between warfarin, dabigatran (Pradaxa), and rivaroxaban (Xarelto) (12/11)
-- Warfarin vs Pradaxa or Xarelto for Atrial Fib
-- CHART
[-] you'll see even more off-label use of atypical antipsychotics (12/11)
-- Off-Label Use of Atypical Antipsychotics in Adults
-- CHART
[-] new strengths of AndroGel and Androderm (testosterone) (12/11)
-- Comparison of Testosterone Products
-- CHART
[-] You'll see a big shift in statin use when atorvastatin (Lipitor) goes generic at the end of November (11/11)
-- Shift in Statin Use with Generic Atorvastatin
-- CHART
[-] controversy over which ORAL anticoagulant to use to prevent strokes in patients with atrial fibrillation (10/11)
-- Oral Anticoagulants
-- CHART
[-] confusing the news about Avandia and Actos (7/11)
-- Actos (Pioglitazone) and Increased Risk of Bladder Cancer
-- CHART
[-] Singulair is "as good as" inhaled corticosteroids or long-acting beta-agonists for asthma (7/11)
-- Leukotriene Antagonists: A New Role in Asthma?
-- CHART
-- Patient Education Handout
[-] HIGHER blood pressure goals in some elderly patients (6/11)
-- Hypertension in the Elderly: Pharmacotherapy Focus
-- CHART
-- Patient Education Handout
[-] more emphasis on the treatment of bipolar disorder (6/11)
-- Pharmacotherapy of Bipolar Disorder in Adults
-- CHART
[-] Tradjenta (TRAD-gen-ta), a new gliptin for type 2 diabetes (6/11)
-- New Drug: Tradjenta (Linagliptin)
-- CHART
[-] testosterone replacement therapy (3/11)
-- Comparison of Testosterone Products
-- CHART
[-] approval of Amturnide means you'll get more questions about when to use TRIPLE combo products for hypertension (3/11)
[-] what they can use to PREVENT migraines (3/11)
-- Drugs Used to Prevent Migraine Headaches
-- CHART
[-] you'll have more options to help patients get a suitable atypical antipsychotic (2/11)
[-] Cycloset, a new form of bromocriptine for type 2 diabetes (2/11)
-- Cycloset: A New Bromocriptine Formulation for Diabetes
-- CHART
[-] whether it's okay for patients with elevated liver enzymes to take a statin (1/11)
-- Statins and the Liver
-- CHART
[-] whether postmenopausal estrogen plus progestin therapy increases breast cancer risk (12/10)
[-] an ultra low-dose Lo Loestrin Fe and Beyaz with added FOLATE (12/10)
-- Lo Loestrin Fe: A New Ultra-Low Dose Oral Contraceptive
-- CHART
[-] possible link between Actos (pioglitazone) and bladder cancer (10/10)
-- Actos (Pioglitazone) and Risk of Bladder Cancer
-- CHART
[-] controversy over the approval of GENERIC enoxaparin (9/10)
-- Approval of Generic Enoxaparin (Lovenox)
-- CHART
[-] whether angiotensin receptor blockers increase cancer or cardiovascular risk (8/10)
-- Angiotensin Receptor Blockers (ARBs) and Cancer Risk
[-] limit use of PPIs (omeprazole, etc) (7/10)
-- Proton Pump Inhibitors: Appropriate Use and Safety Concerns
-- CHART
-- Patient Education Handout
[-] new oral contraceptive called Natazia (estradiol valerate/dienogest) (7/10)
-- Natazia (Estradiol Valerate and Dienogest)
-- CHART
[-] if hormone therapy increases cancer risk (6/10)
-- Postmenopausal Hormone Therapy and Cancer Risk
-- CHART
[-] new statin called Livalo (LIV-al-o, pitavastatin) (6/10)
-- Characteristics of the Various Statins
-- CHART
[-] which is the best drug to add to metformin for type 2 diabetes (5/10)
-- How to Treat Type 2 Diabetes
-- CHART
[-] concerns about using Protopic (tacrolimus) and Elidel (pimecrolimus) for eczema in kids (5/10)
-- Management of Eczema in Children
-- CHART
[-] There's still debate about when and how to taper oral steroids (5/10)
-- Using Oral Corticosteroids: a Toolbox
-- CHART
[-] whether intensive treatment of blood pressure or lipids is beneficial for type 2 diabetes patients (4/10)
-- Intensive Blood Pressure and Lipid Control for Patients with Diabetes: More from ACCORD
-- CHART
[-] three new ORAL drugs for multiple sclerosis...Ampyra, cladribine, and fingolimod (3/10)
[-] Losartan will be the first GENERIC angiotensin receptor blocker (3/10)
-- Comparison of Angiotensin Receptor Blockers
-- CHART
[-] Victoza (VIC-tow-za) will compete with Byetta for type 2 diabetes (3/10)
-- New Drug: Victoza (Liraglutide)
-- CHART
[-] how to choose a long-acting isosorbide product (3/10)
-- Comparison of Nitrate Products
-- CHART
[-] the OTC proton pump inhibitors, Prilosec OTC, Prevacid 24HR, and soon Zegerid OTC (2/10)
-- Comparison of Proton Pump Inhibitors
-- CHART
[-] what to use for uncomplicated vaginal yeast infections (2/10)
-- Treatment of Uncomplicated Vulvovaginal Yeast Infections
-- CHART
[-] The Zetia controversy and New Year's resolutions will spark new emphasis on treating lipids (1/10)
-- Second-Line Therapy of Dyslipidemia
-- CHART
-- Patient Education Handout
[-] Sumavel DosePro, a new NEEDLE-FREE sumatriptan injection for migraines (1/10)
-- Comparison of Available Triptans
-- CHART
[-] how to switch women from oral to topical estrogens (11/09)
-- Converting Between Estrogen Products
-- CHART
[-] Saphris (SA-fris), a new atypical antipsychotic for schizophrenia and bipolar disorder (10/09)
-- Comparison of Atypical Antipsychotics
-- CHART
[-] A growing number of products with probiotics (9/09)
-- Comparison of Common Probiotic Products
-- CHART
-- Patient Education Handout
[-] Lamictal ODT and Lamictal XR tablets add to the confusion of which lamotrigine product to choose (7/09)
-- Choosing the Right Lamotrigine Formulation
-- CHART
[-] new epilepsy drug called Vimpat (lacosamide) (7/09)
-- Comparison of Antiepileptic Drugs
-- CHART
[-] Toviaz (TOE-vee-az) and Gelnique (gel-NEEK) will compete in a crowded market of antimuscarinics for overactive bladder (6/09)
-- Medications for Overactive Bladder
-- CHART
[-] Rapaflo (silodosin), a new selective alpha-blocker for benign prostatic hyperplasia (BPH) (5/09)
-- Comparison of Alpha1-Blockers
-- CHART
[-] generic substitution of long-acting calcium channel blockers (Cardizem CD, Tiazac, etc) (5/09)
-- Comparison of Calcium Channel Blockers
-- CHART
[-] which triptan to use for migraines (5/09)
-- Comparison of Available Triptans
-- CHART
[-] Is chlorthalidone better than hydrochlorothiazide (3/09)
-- Comparison of Commonly Used Diuretics
-- CHART
[-] new proton pump inhibitor called Kapidex (3/09)
-- Comparison of Proton Pump Inhibitors
-- CHART
[-] how Pristiq compares to venlafaxine (Effexor XR, etc) (2/09)
-- Comparison of Venlafaxine and Desvenlafaxine
-- CHART
[-] which bowel prep to use now that most of the OTC sodium phosphate solutions are off the shelves (2/09)
-- Comparison of Bowel Preps
-- CHART
[-] Trilipix (try-LIP-iks) launch is bringing up questions about the appropriate use of fibrates with statins (2/09)
-- Comparison of Fenofibric Acid and Fenofibrate Products
-- CHART
[-] The arrival of Flo-Pred and Veripred 20 will raise more questions about how to select an oral prednisolone product (1/09)
-- Comparison of Oral Prednisolone Formulations
-- CHART
[-] Sancuso patches and Aloxi capsules will be new options for preventing nausea and vomiting due to chemotherapy (11/08)
-- Comparison of Antiemetics
-- CHART
[-] Stavzor adds to the confusion of which valproate product to choose (11/08)
-- Comparison of Divalproex Sodium and Oral Valproic Acid Products
-- CHART
[-] Vitamin K is showing up in more calcium supplements (10/08)
-- Comparison of Oral Calcium Salts
-- CHART
[-] There's confusion about the different oral iron products (8/08)
-- Comparison of Oral Iron Supplements
-- CHART
[-] Chantix should NOT be used by pilots, air traffic controllers, truckers, and bus drivers (7/08)
-- Comparison of Smoking Cessation Drug Therapy
-- CHART
[-] Patients often ask about the right way to use patches (7/08)
-- Characteristics of Transdermal Patches
-- CHART
[-] Patanase (olopatadine) and Omnaris (ciclesonide) nasal sprays for allergic rhinitis (6/08)
-- Nasal Sprays for Allergic Rhinitis
-- CHART
[-] Is it better to use an ACE inhibitor, angiotensin receptor blocker (ARB), or both in patients at risk for heart disease (6/08)
-- ACEI, ARB, and Aliskiren Comparison
-- CHART
[-] You'll soon see ads for a new antidepressant called Pristiq (5/08)
-- Comparison of Antidepressants
-- CHART
[-] topical treatments for chronic wound debridement (5/08)
-- Comparison of Chronic Wound Care Products
-- CHART
[-] Evamist is the first estradiol SPRAY for menopausal symptoms (4/08)
-- Postmenopausal Hormone Therapy
-- CHART
[-] Can kids overdose on amoxicillin (4/08)
-- Comparison of Amoxicillin Products
-- CHART
[-] new beta-blocker called Bystolic (buy-STOL-ic) (2/08)
-- Comparison of Oral Beta-Blockers
-- CHART
[-] OTC products for wound care (12/07)
[-] Doribax (doripenem) is the fourth carbapenem antibiotic (12/07)
-- Comparison of Carbapenem Antibiotics
-- CHART
[-] how to choose the right oral contraceptive (12/07)
-- Hormonal Contraception
-- CHART
[-] what to do if a child's antibiotic is accidentally left out of the refrigerator (11/07)
-- Pediatric Oral Antibiotic and Antifungal Suspensions and Liquids
-- CHART
[-] New NIH guidelines will improve asthma treatment (10/07)
-- National Asthma Guidelines Update 2007
-- CHART
-- Patient Education Handout
[-] What should you put in "magic mouthwash" (7/07)
-- Magic Mouthwash
-- CHART
[-] Patients will be asking about Miralax (polyethylene glycol) now that it's being switched from Rx to OTC (5/07)
-- Medications for Constipation
-- CHART
[-] Zaditor and Alaway are two new OTCs to relieve itchy eyes due to allergic conjunctivitis (1/07)
-- Ophthalmic Medications for Allergic Conjunctivitis
-- CHART
[-] differences between muscle relaxants (12/06)
-- Oral Muscle Relaxants
-- CHART
[-] how to store their injectable diabetes meds (9/06)
-- Comparison of Insulins and Injectable Diabetes Meds
-- CHART
[-] reimbursement for Zocor and the new generic simvastatins (8/06)
-- Characteristics of the Various Statins
-- CHART
[-] probiotics for "digestive health" (7/06)
-- Probiotics: An Update
-- CHART
-- Patient Education Handout
[-] prescription topical steroids aren't safe enough for OTC use (3/06)
-- Comparison of Topical Corticosteroids
-- CHART
[-] Avandaryl, a new combination of rosiglitazone and glimepiride (2/06)
-- Oral Combination Products for Type 2 Diabetes
-- CHART
[-] Sparlon and Daytrana, two new drugs for ADHD (2/06)
-- Drug Treatment for Attention Deficit Hyperactivity Disorder
-- CHART
[-] Are the newer atypical antipsychotics (Zyprexa, etc) better than the older agents for schizophrenia (11/05)
-- Role of Atypical Antipsychotics in Treating Patients with Schizophrenia: Are they Better than the Older Agents?
-- CHART
[-] Ambien CR, a new extended-release zolpidem for insomnia (10/05)
-- Comparison of Insomnia Treatments
-- CHART
-- Patient Education Handout
[-] A new quinolone, Factive, is hitting the market (9/04)
-- Summary of Commonly Used Fluoroquinolones
-- CHART


Home  | Login  | Issues  | Feedback  | Search  | New Drugs  | Email Us  | More >

[*]Top | [#]Bottom